Xiang, H., She, Z., Wang, L., Peng, Y., Zhang, L., Tan, C. (2025). Comparison of Atezolizumab plus Aevacizumab and Atezolizumab plus Aabozantinib for advanced hepatocellular carcinoma: A cost-effectiveness analysis. PLoS ONE. https://doi.org/10.1371/journal.pone.0337606